Sunflower Therapeutics, PBC — Form D
Sunflower Therapeutics, PBC of Hingham, MA, a company, filed a Form D exempt-offering notice with the SEC on 2024-05-24. The offering totals $3.0M, of which $2.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2024-05-24
- Form: D
- Accession: 0001950773-24-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $3.0M
- Amount sold: $2.0M
- Remaining: $970K
- Investors: 2
- Date of first sale: 2024-05-13
- Revenue range: Decline to Disclose
- SEC file number: 021-514263
Issuer
- Name: Sunflower Therapeutics, PBC
- CIK: 0001950773
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2022
- Address: 18 Shipyard Dr., Ste. 2A, Hingham, MA, 02043
- Phone: 781-539-8100
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Maik R Jornitz | Director | Hingham, MA |
| J. Christopher R Love | Director | Hingham, MA |
| Kerry R Love | Director | Hingham, MA |
| Larry R Weiner | Director | Hingham, MA |
| Kerry R Love | Executive Officer | Hingham, MA |
| Kathryn R Golden | Director | Hingham, MA |
Other filings by this issuer (1)
More